Leonardo Mottola

An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response

Alessandra Mangia, Alexander Thompson, Rosanna Santoro et al. · Gastroenterology · 2010 · 316 citations · Full text

Life Sciences, Genetics, Immunology +13

Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial

Alessandra Mangia, Nicola Minerva, Donato Bacca et al. · Hepatology · 2007 · 250 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

Alexander Thompson, Rosanna Santoro, Valeria Piazzolla et al. · Hepatology · 2010 · 73 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

Alessandra Mangia, Alexander Thompson, Rosanna Santoro et al. · Hepatology · 2011 · 57 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Downʼs Syndrome and Celiac Disease

M. Castro, Antonino Crinò, B. Papadatou et al. · Journal of Pediatric Gastroenterology and Nutrition · 1993 · 50 citations

Life Sciences, Immunology, Pathology +17